Materno-foetal transmission of hepatitis B in Saudi Arabia. 1984

A H Basalamah, and F Serebour, and E Kazim

Carriage of hepatitis B among pregnant women in Saudi Arabia and their new born infants has been studied over a period of three years. The hepatitis B surface antigen (HBsAg) carrier rate among 5000 women screened antenatally was 2 X 8 per cent. Hepatitis B subtype ayw was found more often than subtype adw. A study of 50 persistent HBsAg carriers and their newborn infants followed serologically over a period of at least two years did not reveal any evidence of materno-foetal transmission either vertically, perinatally or postnatally. Twelve per cent of mothers shown to be carrying hepatitis B 'e' antigen (HBeAg) during pregnancy did not apparently transmit the virus to their newborn infants. Materno-foetal transmission of hepatitis B virus in utero or during the perinatal period does not seem to be important in maintaining the carrier state in Saudi Arabia, horizontal rather than vertical being the main route of transmission of the virus in this country.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti

Related Publications

A H Basalamah, and F Serebour, and E Kazim
January 2000, The Journal of the Egyptian Public Health Association,
A H Basalamah, and F Serebour, and E Kazim
December 1984, Annals of tropical paediatrics,
A H Basalamah, and F Serebour, and E Kazim
February 1989, The Journal of tropical medicine and hygiene,
A H Basalamah, and F Serebour, and E Kazim
July 1995, Annals of Saudi medicine,
A H Basalamah, and F Serebour, and E Kazim
January 1991, The Journal of the Egyptian Public Health Association,
A H Basalamah, and F Serebour, and E Kazim
November 1985, Journal of medical virology,
A H Basalamah, and F Serebour, and E Kazim
January 1986, Infection,
A H Basalamah, and F Serebour, and E Kazim
January 2015, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
A H Basalamah, and F Serebour, and E Kazim
March 2004, Saudi medical journal,
Copied contents to your clipboard!